Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-15-008723)

Filing Details

Accession Number:: 0001104659-15-008723
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-11 12:32:53
Reporting Period:: 2015-02-10

Filing Date:: 2015-02-11
Accepted Time:: 2015-02-11 12:32:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890465	Nps Pharmaceuticals Inc	NPSP	Biological Products, (No Disgnostic Substances) (2836)	870439579

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1577637	E Susan Graf	550 Hills Drive Bedminster NJ 07921	Vp, Corp Development & Strateg	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-10	6,711	$14.90	10,511	No	4	M	Direct
Common Stock	Disposition	2015-02-10	6,711	$45.87	3,800	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (right to buy)	Disposition	2015-02-10	6,711	$0.00	6,711	$14.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
41,289		2023-06-17	No	4	M	Direct

Footnotes

On June 17, 2013, the reporting person received a grant of 48,000 stock options under NPS Pharmaceuticals Inc.'s amended and restated 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant and 6.25% every three months thereafter.